Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Aniracetam | CDP-Choline (Citicoline) | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 750-1500 mg/day divided into 2-3 doses | 250-500 mg/day |
| Timing | With fat-containing meals (fat-soluble compound; bioavailability increases significantly with dietary fat) | Morning or split morning/afternoon. With or without food. |
| Cycle Duration | Cycles of 8-12 weeks on, 4 weeks off | Ongoing; no cycling required |
| Evidence Level | moderate_human | strong_human |
Potent positive allosteric modulator of AMPA receptors with 5-10x the potency of piracetam, slowing both channel closing rate and microscopic desensitization rates. Also modulates metabotropic glutamate receptors (mGluRs), activates nicotinic acetylcholine receptors, and indirectly boosts dopaminergic and serotonergic neurotransmission, conferring anxiolytic properties.
750-1500 mg/day divided into 2-3 doses
With fat-containing meals (fat-soluble compound; bioavailability increases significantly with dietary fat)
Cycles of 8-12 weeks on, 4 weeks off
Prodrug that is hydrolyzed to choline and cytidine upon oral ingestion. Choline supports acetylcholine synthesis and phosphatidylcholine membrane repair. Cytidine is converted to uridine, which enhances synaptic membrane synthesis via the Kennedy pathway and upregulates dopamine receptor density. This dual mechanism — cholinergic support plus dopaminergic modulation — is unique among choline sources.
250-500 mg/day
Morning or split morning/afternoon. With or without food.
Ongoing; no cycling required
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →